SAP Concur Consultant long-term contract ESSENTIAL SKILLS: Supports multiple Feature Teams in complex Products... of working. This includes facilitating meetings with Domain Owner, decision making and conflict resolution. SAP Module...
SAP ABAP Developer long-term contract position ESSENTIAL SKILLS: At least 6+ years’ experience in ABAP... understanding of SAP Logistics Testing and Test Phases (including Test Automation via TOSCA) S/4 technical knowledge...
SAP ERP Platform Manager (Basis) long-term contract ESSENTIAL SKILLS: Proven experience within SAP systems... security hardening. Strong understanding of SAP security concepts and experience with SAP security tools and technologies...
of or experience in SAP and E-Scripting Drug and family planning, and complementary medicine Duties and Responsibilities: Assist... Knowledge of or experience in Unisolv, SAP and E-Scripting Drug and family planning, and complementary medicine Special...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »